Using Isosorbide Mononitrate in Reducing Time in Induction of Labor in Post Date Women
NCT ID: NCT03854383
Last Updated: 2019-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
100 participants
INTERVENTIONAL
2019-03-03
2019-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor
NCT03523754
Isosorbide Mononitrate in Induction of Labour
NCT04482881
Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor
NCT03863392
Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion
NCT03407521
Titrated Oral Misoprostol Compared to Vaginal Dinoprostone for Induction of Labor
NCT02036437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Misoprostol alone
Enrolled women will receive 25 πg of misoprostol which will be placed intravaginally 4 hourly, maximum up to 5 doses
Misoprostol
Used intravaginally to ripe the cevix in induction of labor
Isosorbide mononitrate with misoprostol
Enrolled women will receive 25 πg of misoprostol together with 40 mg isosorbide mononitrate which will be placed intravaginally 4 hourly, maximum up to 5 doses
Isosorbide mononitrate
Administration of isosorbide mononitrate vaginaly together with misoprostol in induction of labor in postdate women
Misoprostol
Used intravaginally to ripe the cevix in induction of labor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isosorbide mononitrate
Administration of isosorbide mononitrate vaginaly together with misoprostol in induction of labor in postdate women
Misoprostol
Used intravaginally to ripe the cevix in induction of labor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* single fetus
* gestational age \> 40weeks
* not in labor
* bishop score \< 7
* no medical disorder
Exclusion Criteria
* patient with a ripe cervix
* rupture of membranes
* suspected chorioamnionitis
* placenta previa
* history of major uterine surgery
* hypertonic uterine pattern
* contraindicated to receive PG
* fetal malpresentation
* multiple pregnancy
* intrauterine growth retardation
* women with any general medical disorder
20 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abdelrahman Ali Fadel Youssef Mohamed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelrahman Ali Fadel Youssef Mohamed
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams maternity hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
600181
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.